The expression of SGLT2 in murine (and human) lung adenocarcinomas seems to suggest a direct inhibition of SGLT2is on cancer cell glucose uptake, as confirmed by PET imaging studies with the SGLT-specific tracer Me4FDG [14]. This evidence concerns the gene SLC5A2 and cancer.